MONAGHAN MEDICAL CORP.

Monaghan Medical Corporation (MMC) is a global leader in the development and manufacture of innovative aerosol drug delivery devices and respiratory management products for asthma, COPD, bronchiectasis, and other respiratory illnesses. The company operates a state-of-the-art aerosol research laboratory and serves patients, caregivers, and pharmaceutical companies worldwide. MMC offers a comprehensive product portfolio including nebulizers, spacer/holding chambers, peak flow meters, and positive expiratory pressure (OPEP) devices. Core product lines include the AEROECLIPSE II BAN nebulizer, AEROCHAMBER PLUS and AEROCHAMBER2GO spacer chambers with FLOW-VU technology, AEROBIKA OPEP device, AEROVENT PLUS CHC, TRUZONE peak flow meter, and AEROVERSE system. Products are available by prescription through select pharmacies nationwide and are supported by local territory managers. The company emphasizes clinical efficacy and infection control; recent research demonstrates that AEROBIKA and AEROECLIPSE XL R BAN devices resist Mycobacterium avium biofilm formation. All products require a prescription and are designed for both pediatric and adult patients. MMC maintains FDA regulatory compliance and positions itself as an award-winning innovator in respiratory care, with participation in major clinical conferences including the American Thoracic Society (ATS).